The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.

About Followers

Latest preprint reviews

  1. Paired SARS-CoV-2 spike protein mutations observed during ongoing SARS-CoV-2 viral transfer from humans to minks and back to humans

    1. Scott Burkholz
    2. Suman Pokhrel
    3. Benjamin R. Kraemer
    4. Daria Mochly-Rosen
    5. Richard T. Carback
    6. Tom Hodge
    7. Paul Harris
    8. Serban Ciotlos
    9. Lu Wang
    10. C.V. Herst
    11. Reid Rubsamen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Quarantine and the risk of COVID-19 importation

    1. J. Arino
    2. N. Bajeux
    3. S. Portet
    4. J. Watmough

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Persistent cellular immunity to SARS-CoV-2 infection

    1. Gaëlle Breton
    2. Pilar Mendoza
    3. Thomas Hägglöf
    4. Thiago Y. Oliveira
    5. Dennis Schaefer-Babajew
    6. Christian Gaebler
    7. Martina Turroja
    8. Arlene Hurley
    9. Marina Caskey
    10. Michel C. Nussenzweig

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. SARS-CoV-2 RECoVERY: a multi-platform open-source bioinformatic pipeline for the automatic construction and analysis of SARS-CoV-2 genomes from NGS sequencing data

    1. Luca De Sabato
    2. Gabriele Vaccari
    3. Arnold Knijn
    4. Giovanni Ianiro
    5. Ilaria Di Bartolo
    6. Stefano Morabito

    Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

    3 evaluationsAppears in 2 listsLatest version Latest activity

  5. Engineering, production and characterization of Spike and Nucleocapsid structural proteins of SARS–CoV-2 in Nicotiana benthamiana as vaccine candidates against COVID-19

    1. Tarlan Mamedov
    2. Damla Yuksel
    3. Merve Ilgın
    4. İrem Gürbüzaslan
    5. Burcu Gulec
    6. Gulshan Mammadova
    7. Deniz Say
    8. Gulnara Hasanova

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Modelling strategies to organize healthcare workforce during pandemics: Application to COVID-19

    1. Daniel Sánchez-Taltavull
    2. Violeta Castelo-Szekely
    3. Daniel Candinas
    4. Edgar Roldán
    5. Guido Beldi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Economic benefits of COVID-19 screening tests

    1. Andrew Atkeson
    2. Michael Droste
    3. Michael J. Mina
    4. James H. Stock

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Antigenic variation of SARS‐CoV‐2 in response to immune pressure

    1. Diego Forni
    2. Rachele Cagliani
    3. Chiara Pontremoli
    4. Alessandra Mozzi
    5. Uberto Pozzoli
    6. Mario Clerici
    7. Manuela Sironi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. A longitudinal comparison of spike and nucleocapsid SARS-CoV-2 antibody responses in a tertiary hospital’s laboratory workers with validation of DBS specimen analysis

    1. I Murrell
    2. D Forde
    3. L Tyson
    4. L Chichester
    5. A Garratt
    6. O Vineall
    7. N Palmer
    8. R Jones
    9. C Moore

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France

    1. Laura Di Domenico
    2. Chiara E Sabbatini
    3. Giulia Pullano
    4. Daniel Lévy-Bruhl
    5. Vittoria Colizza

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Newer Page 1709 of 2361 Older